Key points are not available for this paper at this time.
tumors in vivo. CAT/9A8 CART is being tested in a phase I clinical study (NCT02443831).
Share your take
Add a clinician perspective alongside expert commentary.
Kokalaki et al. (Tue,) studied this question.